Bayer takes a shine to Berkeley Light's Beacon biologics workflow tech

By Dan Stanton contact

- Last updated on GMT

Bayer will use Berkeley Lights' 'Beacon' tech platform. Image: AlekseySagitov/GettyImages
Bayer will use Berkeley Lights' 'Beacon' tech platform. Image: AlekseySagitov/GettyImages

Related tags: Bacteria, Gene

Bayer has signed a deal to use Berkeley Lights’ automated biological workflow platform for cell line development and antibody discovery.

The aim is to use Berkeley Lights Inc’s Beacon platform to improve drug development processes at Bayer’s research facility in the North Rhine-Westphalia region of Germany.

“Berkeley Lights' Beacon platform enables scientists working in biopharma and academic medical centres to pre-programme and automate workflows to import, culture, assay, view and export single cells within a nanofluidic chip,”​ Eric Hobbs, CEO of the Californian firm, told Biopharma-Reporter.

“Each chip has thousands of nano-size pens (chambers) in which cells are placed to be cultured and assayed. The platform allows scientists to test cells for various properties to identify the best cells based upon user specified characteristics, and then remove those cells for further development.”

The Beacon machine is about the size of a large refrigerator, he added, and replaces rooms full of equipment that are manually operated in biopharma discovery and development labs. It can also be used for cell line development, antibody discovery and engineering, gene editing, and research.

This includes “a variety of cell types including mammalian, microbial and others. We can move cells that are greater than two microns and have moved yeast cells successfully.”

Financial details of the arrangement with Bayer remain under wraps, but Hobson said the deal is not exclusive and Berkeley Lights currently works with a number of other biopharma firms, including eight of the top 20.

Related news

Show more

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

Related suppliers

Follow us

Products

View more

Webinars